Home | AI powered stock trade ideas | Market Signals | Breaking Out | New Green Signal Stocks | Recent Red Arrow Top Signals | Recent Green Arrow Bottom Signals | Near Term Bottom Signals | Green Stocks with Most Upside to Analyst Target Price | New Long Term Green AI Signals | Big Tech Stocks | ETF Sector SPDRs | Solar Stocks | Chip Stocks | Airline Stocks | Social Media Stocks | Oil Stocks| Discount Store Stocks | Entertainment Stocks | EV Stocks | Restaurant Stocks | Heavy Equipment Stocks | Aerospace Stocks | Home Builders | Bank Stock Signals | Cruise Ship Stock Signals | Mining Stocks | Free AI Portfolio Analyzer | How to Read and Trade AI Powered Stock Charts| Stock Charts AI top 50 Stocks

Recently Featured Stock Charts
86% AI Stock Prediction Accuracy
Enter Stock Symbol to View AI powered Stock Chart

StockChartsAI.com

All Chart Prices Delayed at least 15 minutes

Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.

Last Price: 10.85 - Change: 0.07 - Change %: 0.6494
05/24/2024 16:01:00 EST

Maravai Lifesciences Holdings Inc (MRVI)

Industry: Biotechnology

Price Support Resistance

In the past 20 trading days, MRVI has been trading in a range between $11.34 and $7.85 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.

MRVI is trading below resistance at $11.34, about 5% to the upside. There is support at $8.11 -25% to the downside. If it can break above the resistance, it could have some more upside. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.

Upside / Downside Potential

Maravai Lifesciences Holdings Inc $MRVI entered a Green zone 20 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $13, a potential upside of 20.59% from the recent price of 10.78. The stock is trading 38.03% (potential upside) below its 52 week high of $14.88 and 138.5 % (potential downside) above its 52 week low of $4.52 - based on the recent price.

Company Summary

Maravai LifeSciences Holdings, Inc, a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species.

MRVI Website

News

Maravai (MRVI) Advances in RNA Research With New Collaboration
Per Maravai LifeSciences (MRVI) management, this development by TriLink is set to advance nucleic acid-based therapies.
Source: Zacks Investment Research
Fri, 17 May 2024 12:56:05 -0400
Sentiment: Positive
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies (TriLink®), a Maravai™ LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, is collaborating with the Johns Hopkins University to accelerate transformational research in RNA therapeutics and discovery. A new center within the Johns Hopkins Whiting School of Engineering will accelerate research and therapeutic development, leveraging TriLink's leading RNA synthesis technology. TriLink's investment inclu.
Source: Business Wire
Mon, 13 May 2024 08:00:00 -0400
Sentiment: Neutral
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the months of May and June.
Source: GlobeNewsWire
Thu, 09 May 2024 16:05:00 -0400
Sentiment: Neutral
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2024 Earnings Call Transcript
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q1 2024 Earnings Conference Call May 8, 2024 5:00 PM ET Company Participants Debbie Hart - Head, Investor Relations Trey Martin - Chief Executive Officer Kevin Herde - Chief Financial Officer Drew Burch - President, Nucleic Acid Production Becky Buzzeo - Chief Commercial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Tejas Savant - Morgan Stanley Dan Leonard - UBS Tom Peterson - Baird Matt Larew - William Blair Bob Yan - Bank of America Securities Operator Good day, ladies and gentlemen. And welcome to the First Quarter 2024 Maravai LifeSciences Earnings Conference Call.
Source: Seeking Alpha
Wed, 08 May 2024 20:59:08 -0400
Sentiment: Neutral
Maravai LifeSciences Reports First Quarter 2024 Financial Results
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation
Source: GlobeNewsWire
Wed, 08 May 2024 16:05:00 -0400
Sentiment: Neutral
Instituions Institution %: 104.793
Last QTR Institution change: 6427964

Insiders
Insiders %: 1.297
Insiders Purchases last QTR: 0
Insiders Sales last QTR: 0
Insiders Net last QTR: 0

Analyst Ratings
Target Price: 13
Overall Rating: 4.3846
Strong Buys (5): 8
Buys (4): 2
Holds (3): 3
Sells (2): 0
Strong Sells (1): 0

Technicals
52 Week Hi: 14.88
52 Week Low: 4.52
Beta: 0.028
50 Day MA: 8.8636
200 Day MA: 7.7411

Earnings / Revenue Trends
Qtr Earnings Growth YOY: -0.327
Qtr Revenue Growth YOY: -0.188
Forward PE: 30.3951
Trailing PE: 0

Benefits of StockChartsAI.com System:

  • Get a Daily List of Stocks Starting New Trends
  • Upload Your Stocks to Quickly See and Track Signals
  • Easy to Understand AI Stock Signals
  • Analysis of Historical Signal Trend Analysis for each stock
  • Search/View AI Stock Signals of Russel 1000 Stocks
  • Easy to Understand AI Stock Signals
  • And MUCH MUCH more!

1000

Stock Analyzed Each Night

Portfolio

Easily Upload Track Your Stocks

Trends

See Lists of Stocks Starting New Trends

The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.